Novateor Research Laboratories launches SmiloShine Herbafresh toothpaste

0 min read     Updated on 15 Jun 2026, 02:13 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Novateor Research Laboratories launched SmiloShine Herbafresh Toothpaste in a 6 grams sachet on June 15, 2026. The product, containing 8 herbs, targets the hotel and travel segment to expand the company's domestic and international FMCG footprint.

powered bylight_fuzz_icon
43058607

*this image is generated using AI for illustrative purposes only.

Novateor Research Laboratories has expanded its product portfolio with the launch of SmiloShine Herbafresh Toothpaste in a 6 grams sachet format on June 15, 2026. The new product, formulated with 8 herbs, is designed to target the hotel and travel segment as part of the company's forward integration strategy to strengthen its presence in the domestic and international FMCG market.

The introduction of the sachet packaging is intended to enhance accessibility for consumers in the travel and hospitality sectors. This move aligns with the company's objective to broaden its market reach within the oral care category.

Product Details

The filing provided the following specifications regarding the new product launch:

Attribute Details
Name of the Product SmiloShine Herbafresh Toothpaste, formulated with 8 herbs, 6 grams Sachet
Date of Launch 15 June, 2026
Category of the Product Oral Care FMGC product
Market Scope Both domestic and international market

The disclosure was made to BSE Limited in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Historical Stock Returns for Novateor Research Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%+36.88%-39.87%+262.98%

How will the introduction of the 6-gram sachet format impact Novateor's profit margins compared to traditional tube packaging?

What partnerships or distribution channels is Novateor pursuing to secure contracts within the hotel and travel sectors?

Does Novateor plan to expand this sachet format to other existing product lines in the oral care category?

Novateor Research Laboratories
View Company Insights
View All News
like19
dislike

Novateor reports FY26 profit with qualified audit opinion

1 min read     Updated on 31 May 2026, 12:45 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Novateor Research Laboratories announced its audited standalone financial results for the year and half-year ended March 31, 2026, reporting a net profit of ₹10.12 lakh for the full year. Revenue from operations increased to ₹382.75 lakh from ₹277.73 lakh in the previous year. The statutory auditor, H K Shah & Co., issued a qualified opinion due to non-compliance with AS-2, AS-9, AS-15, and AS-17, specifically regarding inventory valuation, unrealized interest income under legal dispute, lack of gratuity provision, and absence of segment reporting. The board approved the results at a meeting on May 30, 2026.

powered bylight_fuzz_icon
41361099

*this image is generated using AI for illustrative purposes only.

Novateor Research Laboratories reported a net profit of ₹10.12 lakh for the financial year ended March 31, 2026, on a total income of ₹431.62 lakh. The company's board approved the audited standalone financial results for the year and half-year ended March 31, 2026, at a meeting held on May 30, 2026. However, the statutory auditor, H K Shah & Co., issued a qualified opinion, citing deviations from several accounting standards including inventory valuation, revenue recognition, and employee benefits.

The auditors noted that AS-2 (Valuation of Inventories) was not followed as the technical valuation claimed by the company was not quantifiable. Additionally, AS-9 (Revenue Recognition) was not adhered to, as interest income of ₹48.39 lakhs remains unrealized and under legal dispute, alongside ₹142.86 lakhs receivable from the previous year. The report also highlighted non-compliance with AS-15 (Employee Benefits) due to the absence of a provision for gratuity and AS-17 (Segment Reporting) as the company did not identify or report segment information.

For the year ended March 31, 2026, revenue from operations rose to ₹382.75 lakh from ₹277.73 lakh in the previous year. Total expenses increased to ₹420.27 lakh from ₹313.99 lakh. The company reported a basic earnings per share (EPS) of ₹0.17 for FY26, compared to ₹0.17 in the previous year. The half-year ended March 31, 2026, recorded a profit of ₹11.70 lakh, while the corresponding period in the previous year reported a profit of ₹4.86 lakh.

Financial Results for FY26

Particulars Year Ended 31.03.2026 (₹ in Lakhs) Year Ended 31.03.2025 (₹ in Lakhs)
Revenue from Operations 382.75 277.73
Total Income 431.62 325.31
Total Expenses 420.27 313.99
Profit for the Period 10.12 8.18
Basic EPS (₹) 0.17 0.17

The auditors also drew attention to a revaluation of long-lease land at its fair market value of ₹100 lakhs, with a corresponding revaluation reserve of ₹30.15 lakhs. Furthermore, GST turnover aggregating to ₹9.83 lakhs is under reconciliation with the books of account. The trading window for dealing in the company's securities, which closed on April 01, 2026, will reopen 48 hours after the announcement of the audited financial results.

Historical Stock Returns for Novateor Research Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%+36.88%-39.87%+262.98%

What steps will management take to resolve the auditor's qualified opinion regarding revenue recognition and inventory valuation?

How will the legal disputes over ₹48.39 lakhs in unrealized interest income impact the company's liquidity and future cash flows?

Will the company implement a provision for gratuity to comply with AS-15, and how might this affect future expense ratios?

Novateor Research Laboratories
View Company Insights
View All News
like15
dislike

More News on Novateor Research Laboratories

1 Year Returns:-39.87%